Omicron’s message on vaccines: Boosting begets breadth
Cell. 2022 Feb 3;185(3):411-413. doi: 10.1016/j.cell.2022.01.006. Epub 2022 Jan 14. ABSTRACT In this issue of Cell, three studies confirm that SARS-CoV-2 Omicron strongly evades a
Origins of peanut allergy-causing antibodies
Science. 2020 Mar 6;367(6482):1072-1073. doi: 10.1126/science.aba8974. NO ABSTRACT PMID:32139528 | PMC:PMC8063504 | DOI:10.1126/science.aba8974
Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses
Science. 2023 Apr 7;380(6640):eadc9498. doi: 10.1126/science.adc9498. Epub 2023 Apr 7. ABSTRACT Despite the vast diversity of the antibody repertoire, infected individuals often mount antibody responses
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Science. 2020 Aug 14;369(6505):806-811. doi: 10.1126/science.abc6284. Epub 2020 May 20. ABSTRACT The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Science. 2020 Nov 27;370(6520):eabd4250. doi: 10.1126/science.abd4250. Epub 2020 Sep 29. ABSTRACT Understanding humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists
Am J Respir Crit Care Med. 2021 Apr 1;203(7):831-840. doi: 10.1164/rccm.202004-0993OC. ABSTRACT Rationale: GLP-1R (glucagon-like peptide-1 receptor) agonists are approved to treat type 2 diabetes